Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease
Authors:
- Nicholas S HopkinsonNHNicholas S Hopkinson
- Ka Wah LiKLKa Wah Li
- Anthony KehoeAKAnthony Kehoe
- Steve E HumphriesSHSteve E Humphries
- Michael RoughtonMRMichael Roughton
- John MoxhamJMJohn Moxham
- Hugh MontgomeryHMHugh Montgomery
- Michael I PolkeyMPMichael I Polkey
Open Access
- 1 February 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 87 (2) , 385-390
Abstract
Background: Quadriceps weakness is an important complication of chronic obstructive pulmonary disease (COPD) and is associated with impaired exercise capacity and greater mortality. Its etiology is multifactorial, and evidence is growing that it is partly determined by genetic susceptibility. Objective: Using an established cohort, we tested whether quadriceps weakness in patients with COPD is influenced by common variations in the gene for the vitamin D receptor. Design: Vitamin D receptor FokI and BsmI genotypes and the (I/D) angiotensin-converting enzyme (ACE) and bradykinin receptor (+9/−9) genotypes were identified in 107 patients with stable COPD [x̄ ± SD forced expiratory volume in 1 s (FEV1): 34.5 ± 16.5] and 104 healthy, age-matched control subjects. Quadriceps maximum voluntary contraction force and fat-free mass assessed by bioelectrical impedance analysis were measured. Results: After adjustment for covariables, both patients and control subjects who were homozygous for the C allele of the FokI polymorphism had less quadriceps strength than did those with ≥1 T allele [41.0 ± 11.8 compared with 46.0 ± 13.2 kg (P = 0.01) and 32.5 ± 11.2 compared with 36.2 ± 13.1 kg (P = 0.005), respectively]. The b allele of the BsmI polymorphism was associated with greater quadriceps strength in patients—37.0 ± 13.3, 33.8 ± 11.6, and 33.8 ± 11.6 kg for bb, bB, and BB, respectively (P = 0.0005)—but had no effect in healthy control subjects. The effect of BsmI on quadriceps strength was least apparent in patients with the ACE II genotype (P = 0.003). Conclusions: The FokI common variants in the VDR gene are associated with skeletal muscle strength in both patients and control subjects, whereas the BsmI polymorphism is associated with strength only in patients.Keywords
This publication has 49 references indexed in Scilit:
- Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary diseaseThorax, 2007
- Association between Polymorphisms of Vitamin D Receptor Gene ApaI, BsmI and TaqI and Muscular Strength in Young Chinese WomenInternational Journal of Sports Medicine, 2005
- Coactivation of the Human Vitamin D Receptor by the Peroxisome Proliferator-Activated Receptor γ Coactivator-1 αMolecular Pharmacology, 2005
- Insulin-Like Growth Factor Pathway Polymorphisms Associated with Body Size in Hispanic and Non-Hispanic White WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- Regulation of Muscle Fiber Type and Running Endurance by PPARδPLOS Biology, 2004
- Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary diseaseClinical Nutrition, 1999
- Quadriceps and Grip Strength Are Related to Vitamin D Receptor Genotype in Elderly Nonobese WomenJournal of Bone and Mineral Research, 1997
- Osteomalacic myopathyMuscle & Nerve, 1994
- 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathwaysThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- MUSCLE WEAKNESS IN OSTEOMALACIAThe Lancet, 1976